Xencor (XNCR) Other Non Operating Income (2013 - 2026)
Xencor (XNCR) reported Other Non Operating Income of $396000.0 for Q1 2026, up 1377.42% year-over-year from $26803.5 in Q1 2025, and up 5050.0% quarter-over-quarter from -$8000.0 in Q4 2025.
Xencor (XNCR) Other Non Operating Income (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Other Non Operating Income data on file, last reported at $396000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $396000.0, up 1377.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $354000.0 (up 1763.16% YoY), and the FY2025 annual result was -$73000.0, down 246.0% from the prior year.
- Other Non Operating Income climbed to $396000.0 in Q1 2026 per XNCR's latest filing, from -$8000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.4 million in Q4 2023 and troughed at -$1.4 million in Q1 2023.
- A 5-year average of $3500.0 and a median of -$9500.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income tumbled 2350.0% in 2022, then surged 3347.62% in 2023.
- A 5-year view of Other Non Operating Income shows it stood at -$42000.0 in 2022, then surged by 3347.62% to $1.4 million in 2023, then plunged by 95.31% to $64000.0 in 2024, then plunged by 112.5% to -$8000.0 in 2025, then jumped by 5050.0% to $396000.0 in 2026.
- Business Quant data shows XNCR's Other Non Operating Income at $396000.0 in Q1 2026, -$8000.0 in Q4 2025, and -$17000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 396,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Jun 30, 2025 | -17,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Mar 31, 2023 | -1.39 Mn |
| Dec 31, 2022 | -42,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -147,000.00 |
| Mar 31, 2022 | -96,000.00 |
| Dec 31, 2021 | -664,000.00 |
| Sep 30, 2021 | -593,000.00 |
| Jun 30, 2021 | -6,000.00 |
| Mar 31, 2021 | -11,000.00 |